510(k) Report

510(k) · Cleared

Cleared

Pefakit Apc-R Factor V Leiden Controls

K042760510(k) AbbreviatedCleared Dec 22, 200478-day reviewClass II21 CFR 864.5425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pentapharm, Ltd. · GGN Plasma, Coagulation Control

Cleared on Dec 22, 2004 as substantially equivalent to K963111 (Chromogenix AB, 1996) after a 78-day review. Its family tree reaches back 2 generations to 1995.

Decided
Dec 22, 2004
Review
78 days
Class
Class II
Product code
GGN
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K945940 (1995). No later device cites it as a predicate yet.

  1. Root · 2 generations backK945940 Coatest (R) Apc (TM) ResistanceAxis-Shield Doc AS · 1995
  2. 1 generation backK963111 Coatest Apc (TM) Resistance V/Coatest Apc (TM) Resistance V SChromogenix AB · 1996
  3. This deviceK042760 Pefakit Apc-R Factor V Leiden ControlsPentapharm, Ltd. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K945940Coatest (R) Apc (TM) ResistanceAxis-Shield Doc AS1995—
−1K963111Coatest Apc (TM) Resistance V/Coatest Apc (TM) Resistance V SChromogenix AB1996—
0 (this device)K042760Pefakit Apc-R Factor V Leiden ControlsPentapharm, Ltd.2004—
FIG. 1 — Lineage of K042760, 1995–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GGN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K963111Coatest Apc (TM) Resistance V/Coatest Apc (TM) Resistance V S
Summary page 1
…edicate Device Name: COATEST® APCTM RESISTANCE V/ COATEST® APCTM RESISTANCE VS 510(k) Number: K963111 Regulation Number: 864.7925 Regulatory Class: II 4. Description of the d…
Chromogenix AB1996—

Also cleared against K963111: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 3 companies; a new generation was cleared every 8.0 years on median.
  • None of the 2 ancestors has a recall.
  • 4 other devices also cite its predicate K963111.

How does its category compare?

All GGN devices

GGN Plasma, Coagulation Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GGN

4in 2017

2007: 32008: 12009: 22010: 32011: 22012: 12013: 32014: 22016: 22017: 4
2007high 4 (2017) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GGN

96in 2017

2007: 47 days median2010: 23 days median2013: 441 days median2017: 96 days median
2007high 441 (2013) · low 23 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GGN

1in 2019

2010: 42011: 12013: 32019: 12026 (partial year): 2
2007high 4 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GGN

4in 2018

2009: 372010: 172011: 302012: 102013: 92014: 52015: 102016: 92017: 112018: 4
2007high 37 (2009) · low 0 (2007)2025

MAUDE reports naming product code GGN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200734700
20081—00
20092—037
2010323417
20112—130
20121—010
2013344139
20142—05
20150—010
20162—09
2017496011
20180—04
20190—10
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—2—

What is it indicated for?

The device is a box containing lyophilized pooled plasmas from donors genotyped for the factor V Leiden mutation (FV: Q506) to be reconstituted with water by the user. Controls contain pooled plasmas of either donors with heterozygous FV:Q506 mutation or normal wild-type pattern. These controls are intended to be used for quality assurance in connection with the IVD device 'Pefakit® APC-R Factor V Leiden'.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K042760: Pefakit Apc-R Factor V Leiden Controls.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K042760

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026